HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tony P George Selected Research

Varenicline (Chantix)

1/2022Dose-dependent effects of Varenicline on tobacco craving and withdrawal in tobacco smokers with and without schizophrenia.
4/2020Pharmacotherapy for smoking cessation in schizophrenia: a systematic review.
1/2018Predicting smoking abstinence with biological and self-report measures of adherence to varenicline: Impact on pharmacogenetic trial outcomes.
1/2018Effects of varenicline on cognitive function in non-smokers with schizophrenia.
12/2017Measures and predictors of varenicline adherence in the treatment of nicotine dependence.
6/2017Sleep Disturbance During Smoking Cessation: Withdrawal or Side Effect of Treatment?
12/2016Effects of varenicline on motor cortical plasticity in non-smokers with schizophrenia.
4/2015An association between the use of hypnotics and quit status in the treatment of nicotine dependence with varenicline in bipolar disorder.
7/2014Varenicline for smoking cessation in bipolar disorder: a randomized, double-blind, placebo-controlled study.
9/2013Varenicline modulates spatial working memory deficits in smokers with schizophrenia.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tony P George Research Topics

Disease

41Schizophrenia (Dementia Praecox)
01/2022 - 01/2002
24Tobacco Use Disorder (Nicotine Dependence)
01/2022 - 04/2002
10Psychotic Disorders (Schizoaffective Disorder)
03/2022 - 07/2002
10Substance-Related Disorders (Drug Abuse)
01/2021 - 04/2002
9Bipolar Disorder (Manic Depressive Psychosis)
01/2020 - 10/2008
5Substance Withdrawal Syndrome (Withdrawal Symptoms)
03/2019 - 07/2008
4Cocaine-Related Disorders (Cocaine Addiction)
03/2014 - 04/2002
3Mental Disorders (Mental Disorder)
01/2021 - 12/2008
3Major Depressive Disorder (Major Depressive Disorders)
01/2021 - 06/2008
3Alcoholism (Alcohol Abuse)
01/2021 - 07/2011
3Mood Disorders (Mood Disorder)
12/2015 - 12/2004
2Confusion (Bewilderment)
01/2022 - 01/2020
2Opioid-Related Disorders (Opiate Addiction)
01/2021 - 07/2002
2Anxiety Disorders (Anxiety Disorder)
01/2020 - 09/2017
2Marijuana Abuse (Cannabis Abuse)
01/2018 - 07/2016
2Cognitive Dysfunction
11/2013 - 12/2004
2Tourette Syndrome (Tourette's Syndrome)
11/2009 - 12/2004
2Gambling (Pathological Gambling)
01/2008 - 10/2004
1Fatigue
01/2020
1Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
01/2020
1Neoplasms (Cancer)
01/2018
1Depressive Disorder (Melancholia)
12/2015
1Antisocial Personality Disorder (Antisocial Personality)
10/2013
1Heroin Dependence (Heroin Abuse)
07/2011
1Hyponatremia
06/2010
1Polydipsia
06/2010
1Hypertension (High Blood Pressure)
11/2009
1Brain Diseases (Brain Disorder)
11/2008
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
12/2004
1Parkinson Disease (Parkinson's Disease)
12/2004
1Alzheimer Disease (Alzheimer's Disease)
12/2004
1Headache (Headaches)
11/2003

Drug/Important Bio-Agent (IBA)

25NicotineFDA Link
01/2022 - 04/2002
13Varenicline (Chantix)FDA Link
01/2022 - 06/2010
10Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
12/2016 - 12/2004
7Dopamine (Intropin)FDA LinkGeneric
07/2014 - 01/2002
7MecamylamineIBA
12/2009 - 04/2005
5Pharmaceutical PreparationsIBA
01/2022 - 10/2004
5Dronabinol (THC)FDA LinkGeneric
01/2021 - 07/2016
5Bupropion (Wellbutrin)FDA LinkGeneric
04/2020 - 07/2002
5Opioid Analgesics (Opioids)IBA
11/2019 - 07/2002
5SmokeIBA
10/2016 - 01/2002
4Biomarkers (Surrogate Marker)IBA
07/2018 - 01/2018
4gamma-Aminobutyric Acid (GABA)IBA
03/2017 - 01/2004
3CannabidiolIBA
01/2021 - 07/2016
3Cocaine (Cocaine HCl)IBA
01/2021 - 11/2008
3Neurotransmitter Agents (Neurotransmitter)IBA
07/2014 - 01/2004
3Topiramate (Topamax)FDA LinkGeneric
01/2010 - 04/2008
32- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
01/2008 - 06/2005
2EndocannabinoidsIBA
03/2022 - 01/2004
2CannabinoidsIBA
03/2022 - 01/2020
2salicylhydroxamic acid (SHAM)IBA
01/2022 - 01/2018
2KetamineFDA LinkGeneric
01/2021 - 01/2020
2nabiximols (Sativex)IBA
01/2018 - 07/2016
2Glutamic Acid (Glutamate)FDA Link
07/2014 - 01/2004
2Disulfiram (Antabuse)FDA Link
03/2014 - 04/2002
1Lysergic Acid Diethylamide (LSD)IBA
01/2022
1Amphetamine (Amfetamine)FDA LinkGeneric
01/2021
1Antipsychotic Agents (Antipsychotics)IBA
01/2021
1Psychotropic Drugs (Psychoactive Drugs)IBA
01/2021
1N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA
01/2021
1Antidepressive Agents (Antidepressants)IBA
01/2020
1Valproic Acid (Depakote)FDA LinkGeneric
11/2019
1Lamotrigine (Lamictal)FDA LinkGeneric
11/2019
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2018
1Gemfibrozil (Lopid)FDA LinkGeneric
01/2018
1CreatinineIBA
01/2018
1Cholinergic Agents (Cholinergics)IBA
01/2018
1GABA Receptors (GABA Receptor)IBA
03/2016
1Hypnotics and Sedatives (Sedatives)IBA
04/2015
1Polytetrafluoroethylene (Teflon)FDA Link
03/2015
1Heroin (Diamorphine)IBA
12/2014
1Aminobutyrates (Aminobutyric Acid)IBA
07/2014
1Buprenorphine (Subutex)FDA LinkGeneric
03/2014
1Mixed Function Oxygenases (Monooxygenases)IBA
03/2014
1naxagolideIBA
01/2014
1Dopamine Receptors (Dopamine Receptor)IBA
01/2014
1Naltrexone (ReVia)FDA LinkGeneric
07/2011
1Antihypertensive Agents (Antihypertensives)IBA
11/2009
1Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric
02/2009
1Galantamine (Galanthamine)FDA LinkGeneric
08/2008
1Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
06/2008
1Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2004
1Serotonin (5 Hydroxytryptamine)IBA
01/2004
1Acetylcholine (Acetylcholine Chloride)FDA Link
01/2004
1Methadone (Dolophine)FDA LinkGeneric
11/2003
1Tiagabine (Gabitril)FDA Link
11/2003
1Monoamine Oxidase (MAO)IBA
01/2003
1Selegiline (E250)FDA LinkGeneric
01/2003
1Pergolide (Permax)FDA Link
04/2002
1Mazindol (Mazanor)FDA Link
04/2002

Therapy/Procedure

12Drug Therapy (Chemotherapy)
04/2020 - 01/2005
9Transcranial Magnetic Stimulation
01/2022 - 11/2008
7Therapeutics
09/2017 - 10/2007
2Nicotine Replacement Therapy
04/2020 - 07/2011
2Self Medication
12/2015 - 12/2008
2Tobacco Use Cessation Devices
09/2009 - 06/2008
1Transcranial Direct Current Stimulation
01/2022
1Injections
01/2021
1Secondary Prevention
07/2016